Capricor Therapeutics
CAPR
#6003
Rank
S$1.48 B
Marketcap
S$25.56
Share price
1.49%
Change (1 day)
218.79%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2026 (TTM): -S$0.15 Billion

According to Capricor Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$0.14 Billion a decrease over its 2024 earnings that were of -S$52.26 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.15 Billion8.33%
2025 -S$0.14 Billion159.57%
2024 -S$52.26 Million81.57%
2023 -S$28.79 Million-23.2%
2022 -S$37.48 Million44.93%
2021 -S$25.86 Million46.61%
2020 -S$17.64 Million78.71%
2019 -S$9.87 Million-49.7%
2018 -S$19.62 Million-724.78%
2017 S$3.13 M-112.93%
2016 -S$24.29 Million46.27%
2015 -S$16.61 Million106.82%
2014 -S$8.03 Million-48.41%
2013 -S$15.57 Million977.23%
2012 -S$1.45 Million-77.11%
2011 -S$6.32 Million-22.35%
2010 -S$8.13 Million-20.17%
2009 -S$10.19 Million-41.17%
2008 -S$17.31 Million41.05%
2007 -S$12.27 Million1098.87%
2006 -S$1.03 Million4101.55%
2005 -S$0.03 Million-0.97%
2004 -S$0.03 Million17.87%
2003 -S$0.03 Million3.66%
2002 -S$0.03 Million-30.11%
2001 -S$0.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.54 B-22,770.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$1.03 B-797.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-S$1.08 Billion 623.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.4 Billion 169.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-S$8.07 Million-94.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-S$19.27 Million-86.98%๐Ÿ‡บ๐Ÿ‡ธ USA